The Lancet Infectious Diseases is a high-impact, peer-reviewed journal focusing on the prevention, diagnosis, and treatment of infectious diseases worldwide. It delivers authoritative, accessible, and timely original research, reviews, and commentary on the latest developments in the field. Its scope encompasses viral, bacterial, fungal, and parasitic infections, as well as emerging infectious threats.
Key topics covered include epidemiology, clinical microbiology, immunology, antimicrobial resistance, and global health security. The journal offers insights into disease outbreaks, treatment strategies, and prevention measures. Indexed in major databases, The Lancet Infectious Diseases serves as a key resource for clinicians, researchers, and public health professionals involved in the fight against infectious diseases. Its target audience includes infectious disease specialists, microbiologists, epidemiologists, and policymakers.
It aims to be a leading source of information on infectious diseases and contribute to improved global health outcomes. Researchers are invited to submit their work and engage in the ongoing effort to combat infectious diseases worldwide.